Breaking News

You are here » Indian-Commodity  :  Corporate  :  JSW Steel executes a share purchase agreement with Praxair India

16-Aug2016

JSW Steel executes a share purchase agreement with Praxair India

JSW Steel has executed a Share Purchase Agreement with Praxair India to acquire their entire shareholding of 74% in JSW Praxair Oxygen (JPOPL) for a cash consideration of Rs 240 crore. The company currently holds 26 percent of the equity shares of JPOPL and post the aforesaid acquisition, JPOPL would become a wholly owned subsidiary of JSW Steel.

JPOPL is engaged in the business of production and sale of industrial gases such as oxygen, nitrogen and argon and has set up two air separation plants, each with a capacity of 2500 tonnes per day, at Toranagallu, Bellary District in Karnataka JSW Steel currently sources industrial gases from JPOPL amongst others at prices based on long term contracts.

The said acquisition is strategic in nature as it will provide the Company the benefit of backward integration of this critical input. Deloitte Touche Tohmatsu India LLP and Bharucha & Partners, Advocates and Solicitors carried out financial and legal due diligence respectively for the Company.


Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......